For the Inventor, By the Inventor

Enter assignee name

West Caldwell, NJ, United States of America

Alfa Wassermann, Inc.

USPTO Granted Patents = 88

CIPO Patents = 14

EPO Patents = 19

Trademarks = 12

Forward Citations = 1,260

Loading Chart...

Loading Chart...

94 inventors (with patents filed for the assignee):

Giuseppe Claudio Viscomi (29 out of 40 patents)

Manuela Campana (21 out of 22 patents)

Donatella Confortini (21 out of 22 patents)

4. Dario Braga (17 out of 22 patents)

5. Vincenzo Cannata (14 out of 29 patents)

6. Goffredo Rosini (14 out of 16 patents)

7. Egidio Marchi (11 out of 20 patents)

8. Paolo Righi (11 out of 11 patents)

9. Kurt Spiegel (10 out of 10 patents)

10. Blaine J Marsh (9 out of 9 patents)

11. Silvano Piani (8 out of 9 patents)

12. Maria Barbanti (7 out of 8 patents)

13. Marchi Egidio (7 out of 7 patents)

14. Leone G Rotini (7 out of 7 patents)

15. Miriam Barbanti (6 out of 6 patents)

88 patents: Sort by Forward Citations

1. 11389810 - Centrifuge rotor core with partial channels (2022-07-19),

2. 10773263 - Systems that prevent operation of continuous flow ultra-centrifugation systems without simultaneous contact of a single safety sensor and a control icon (2020-09-15),

3. 10751733 - Centrifuge rotor core with partial channels (2020-08-25),

4. 10668484 - Fluid handling systems and method for ultracentrifuges (2020-06-02),

5. 10016767 - Centrifugation systems with non-contact seal assemblies (2018-07-10),

6. 9938298 - Solvated crystal form of rifaximin, production, compositions and uses thereof (2018-04-10),

7. 9862936 - Methods of purifying adeno-associated virus (AAV) and/or recombinant adeno-associated virus (rAAV) and gradients and flow-through buffers therefore (2018-01-09),

8. 9725466 - Rifaximin derivative and uses thereof (2017-08-08),

9. 9664597 - Liquid collection methods and apparatuses for detecting virus deactivation (2017-05-30),

10. 9498442 - Rifaximin powder, process for preparing the same an controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect (2016-11-22),

11. 9452157 - Pharmaceutical compositions comprising rifaximin and amino acids, preparation methods and use thereof (2016-09-27),

12. 9405836 - Continuous flow ultra-centrifugation systems (2016-08-02),

13. 9402885 - Method of treating GERD with alpha and beta galactosidases (2016-08-02),

14. 9381523 - Automated fraction collection system (2016-07-05),

15. 9364467 - Rifaximin derivative and uses thereof (2016-06-14),

Alfa Wassermann, Inc. is a reliable and innovative pharmaceutical company that specializes in the development, manufacturing, and commercialization of specialized drugs and medical devices. With a commitment to improving patient outcomes and quality of life, Alfa Wassermann aims to deliver cutting-edge solutions for the global healthcare market. Their focus areas include biopharmaceuticals, specialty therapeutics, diagnostic tools, and clinical chemistry. Visit their website for more information about their products and services.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

88 Patents

#1 in West Caldwell, NJ

#189 in New Jersey

#4,084 in US

#8,413 in the World

West Caldwell, NJ, United States of America

Alfa Wassermann, Inc.

Forward Citations = 1,260

94 inventors:

Giuseppe Claudio Viscomi (29 out of 40 patents)

Manuela Campana (21 out of 22 patents)

Donatella Confortini (21 out of 22 patents)

4. Dario Braga (17 out of 22 patents)

5. Vincenzo Cannata (14 out of 29 patents)

Please report any incorrect information to support@idiyas.com

Loading…